Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
McKinsey
Merck
Harvard Business School
Moodys

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Pfizer Inc. v. Aurobindo Pharma USA Inc. (D. Del. 2017)

See Plans and Pricing

« Back to Dashboard

Pfizer Inc. v. Aurobindo Pharma USA Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-12-08
Court District Court, D. Delaware Date Terminated 2018-05-31
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties AUROBINDO PHARMA USA INC.; PFIZER INC.; PFIZER IRELAND PHARMACEUTICALS; PFIZER LIMITED
Patents 6,124,363
Attorneys Arthur G. Connolly , III; Jack B. Blumenfeld; Maryellen Noreika; Steven J. Moore
Firms Connolly Gallagher LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Pfizer Inc. v. Aurobindo Pharma USA Inc.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Pfizer Inc. v. Aurobindo Pharma USA Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 Aurobindo for patent infringement of United States Patent No. 6,124,363 (the “’363 patent”) arising from…BACKGROUND The ’363 Patent 11. On September 26, 2000, the United States Patent and Trademark Office…) issued the ’363 patent, titled “Dofetilide Polymorphs.” A copy of the ’363 patent is attached hereto…363 patent. 23. On information and belief, Aurobindo had knowledge of the ’363 patent when…the ’363 patent. Aurobindo’s ANDA Products will infringe at least claim 1 of the ’363 patent. External link to document
0000-00-00 14 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number 6,124,363. (etg) (Entered: 07/… 2017 31 May 2018 1:17-cv-01775 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,124,363. (nmfn) (Entered: 12… 2017 31 May 2018 1:17-cv-01775 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Baxter
Medtronic
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.